Matches in Wikidata for { <http://www.wikidata.org/entity/Q87933105> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q87933105 description "clinical trial" @default.
- Q87933105 description "ensayu clínicu" @default.
- Q87933105 description "klinisch onderzoek" @default.
- Q87933105 description "клінічне випробування" @default.
- Q87933105 name "Efficacy and Safety APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)" @default.
- Q87933105 name "Efficacy and Safety APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)" @default.
- Q87933105 type Item @default.
- Q87933105 label "Efficacy and Safety APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)" @default.
- Q87933105 label "Efficacy and Safety APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)" @default.
- Q87933105 prefLabel "Efficacy and Safety APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)" @default.
- Q87933105 prefLabel "Efficacy and Safety APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)" @default.
- Q87933105 P1050 Q87933105-371711C6-5B47-4D34-A6EB-0E3E2A3B51DD @default.
- Q87933105 P1050 Q87933105-FEA7C4A7-6B92-4849-A0ED-3CFEF18DDDC3 @default.
- Q87933105 P1132 Q87933105-26717607-9776-45D6-8B45-2A3A7CCBD086 @default.
- Q87933105 P1476 Q87933105-0BB28929-AF7B-40AD-81DB-A5A90DBBF2DB @default.
- Q87933105 P17 Q87933105-312CA9BB-E971-4392-B751-331E696CFD33 @default.
- Q87933105 P1813 Q87933105-E5CED8AE-8AD4-4B20-BDF9-C22D72A86CE3 @default.
- Q87933105 P2899 Q87933105-0022F1E5-E328-4253-8CA1-AD2C1C1EBFBE @default.
- Q87933105 P3098 Q87933105-07C76286-20ED-4AA2-92B7-3786837DF416 @default.
- Q87933105 P31 Q87933105-481FA87F-1678-4900-89AD-3AC13D2287B4 @default.
- Q87933105 P4844 Q87933105-0020517F-9DE0-4256-93B1-60CD768369CD @default.
- Q87933105 P580 Q87933105-F63DF1BC-AE20-418B-9AF1-57C6764B650A @default.
- Q87933105 P582 Q87933105-A053D3DA-3F8D-4126-BDE8-17CD2B5FBA40 @default.
- Q87933105 P6099 Q87933105-4AB4A36B-A6D4-41F3-AC75-D38E39D37A18 @default.
- Q87933105 P8363 Q87933105-E44FBE96-1AA4-4D87-B159-6518FF6008CF @default.
- Q87933105 P921 Q87933105-1346AA1C-195D-4CC2-A15D-BD8521BF624A @default.
- Q87933105 P921 Q87933105-162F44EB-F626-45F6-831B-2798C723FD58 @default.
- Q87933105 P921 Q87933105-2787530F-8FF0-46A9-9538-8EF8DEE2A2A0 @default.
- Q87933105 P921 Q87933105-5F19DAEA-60E7-4104-894D-78EE3CF65116 @default.
- Q87933105 P1050 Q2057356 @default.
- Q87933105 P1050 Q298230 @default.
- Q87933105 P1132 "+120" @default.
- Q87933105 P1476 "Fluticasone Propionate Oral Dispersible Tablet Formulation in Eosinophilic Esophagitis: A Two-Part, Randomized, Double-blind, Placebo-Controlled Study of APT-1011 in Adult and Adolescent Subjects With Eosinophilic Esophagitis" @default.
- Q87933105 P17 Q30 @default.
- Q87933105 P1813 "FLUTE-2" @default.
- Q87933105 P2899 "+15" @default.
- Q87933105 P3098 "NCT04281108" @default.
- Q87933105 P31 Q30612 @default.
- Q87933105 P4844 Q1002165 @default.
- Q87933105 P580 "2020-01-30T00:00:00Z" @default.
- Q87933105 P582 "2021-10-31T00:00:00Z" @default.
- Q87933105 P6099 Q42824827 @default.
- Q87933105 P8363 Q78089383 @default.
- Q87933105 P921 Q1002165 @default.
- Q87933105 P921 Q188724 @default.
- Q87933105 P921 Q50430264 @default.
- Q87933105 P921 Q50430265 @default.